Navigation Links
Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
Date:8/27/2007

Live Webcast from the Millennium Broadway Hotel in New York on Thursday,

September 6th

SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, today announced that John P. Longenecker, Ph.D., President and Chief Executive Officer, will present at the NewsMakers in the Biotech Industry investment conference at 9:00 a.m. Eastern time on Thursday, September 6, 2007. The conference, presented by BioCentury and Thomson, will be held at the Millennium Broadway Hotel in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

Dr. Longenecker will provide an overview of Favrille and the clinical trials of its lead compound, FavId(R), which is currently in a pivotal Phase 3 clinical trial for the treatment of follicular B-cell non-Hodgkin's lymphoma (NHL). A live webcast of the presentation can be accessed at http://www.favrille.com. The replay will be available approximately one hour after the presentation and will be archived until October 6, 2007.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidat
'/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corpo...mpany") today announced,that the Company plans to ...nday, November 9, 2009, after the market closes. ,...at 5:00 pm ET on November 9, 2009,to discuss third...all by,dialing 1-888-713-4211 or 1-617-213-4864 fo...
(Date:11/4/2009)... which will be presented on November 19 and is of ...istry processing, will deal with the application o...and micro scale flow chemistry equipment. Profess...cognized with several prestigious prizes and award...ize. , Columbia, MD (PRWE...
(Date:11/4/2009)... Zyngenia, Inc., a privately held b...antibody drug development, today announced that it...New Enterprise Associates (NEA), one of the world,...be used to create novel, multi-specific antibody-l...targets with a single agent. The company will init...
(Date:11/4/2009)...irstCall/ - Medicago Inc. (TSX-V: MDG), a biotechn...ve and affordable vaccines based on proprietary ma...(VLPs), today announced that it received an invita...Services (HHS) to present at the Global Health Sec...09 at 2:40 pm (EST) at the Fairfax at Embassy Row ...
Breaking Biology Technology:BMP Sunstone to Report Third Quarter 2009 Financial Results 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4Medicago to present at the U.S. Department of Health and Human Services' Global Health Security Initiative Workshop 2
...,Inc. (Nasdaq: ARNA ) today announced it will rep...e NASDAQ Global Market closes on Tuesday, August,5...esident and Chief,Executive Officer, and Robert E....f Financial Officer, will host a conference call a...to discuss the second quarter 2008,financial resul...
...,local forensic crime labs received evidence from ...uring 2005, according to a report by the Justice,D...ese cases included,requests for a variety of foren...tance identification, and fingerprint examination....not completed within 30,days) at the end of 2005--...
...ting, Standards and Procedures, SHAANXI, China, J...o-,Pharmaceutical Technology, Inc. (OTC Bulletin B...lant extracts and raw materials used in the,produc...roduction, today,released an investor update on th...he delivery of Diosmin to Safic-Alcan., COS, or E...
Other Biology Technology:Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008 2Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008 3Crime Labs Received an Estimated 2.7 Million Cases in 2005 2Crime Labs Received an Estimated 2.7 Million Cases in 2005 3Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 2Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 3
(Date:11/4/2009)...Nov. 4 Glencoe Software, Inc., the... (OME) Consortium ( http://openmicroscopy.org ),...merican Society of Cell Biology,s exciting new pro... has been awarded a $2.5M stimulus grant through t...ortunities program, as part of the American Reinve...
(Date:11/3/2009)...PAINIn a research report published in a recent iss... and Sim Alegre examined the effects of covering o..., fruit quality, canopy light distribution, orchar...were performed using Extenday and Solarmate films ...hards of ,Mondial Gala, apples. The research showe...
(Date:11/3/2009)...rom the UCLA Henry Samueli School of Engineering a...fully reconstituted in the laboratory the enzyme r...ol-lowering drug lovastatin. , The research, ...potentially lead to the development of other compo... lovastatin-synthesizing enzyme is one of the most...
Breaking Biology News(10 mins):Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2Scientists identify specific markers that trigger aggressiveness of liver cancer 59827 1Scientists identify specific markers that trigger aggressiveness of liver cancer 59827 2Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 1Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 2New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 1New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 2New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 3
...year worldwide, causing one million deaths. Around...ung children. One of the greatest challenges facin...stance; resistance to chloroquine (CQ), the cheape...roughout Africa, and resistance to sulfadoxine-pyr...ensive alternative to CQ, is also increasing. Thes...
... is harmless on human skin, but it is the leading ...ns of indwelling medical devices. S. epidermidis i... in people with prosthetic joints, replacement hea...ic resistance makes it tough to battle. Moreover, ...o pathogenic once the protective barrier of the sk...
...cess by which a single gene can initiate productio...ive splicing, said Baylor College of Medicine rese...of the journal Molecular Cell. "A major question i...es produce at least 120,000 proteins," said Dr. Be...lar and cellular biology. The answer is a process ...
Other Biology News:Reducing malarial transmission in Africa 2Controlling protein diversity 2
...AQ systems integrate the unique quantitative and q...0 Q TRAP LC/MS/MS Systems with the new Tempo nano ... rapid solution for high sensitivity validation of...le preparation with high instrument selectivity an...
...XL extends the legendary MSn performance of the LT...tural information through Thermo Scientifics innov...s LTQ XL is the only mass spectrometer that offers...D. Pulsed Q Collision Induced Dissociation (PQD) ...
...orefront of Agilent analytical solutions is the 68... networking (LAN) allows you to share business and...ed decision making. Just as its 6890 GC predecesso...e needed for research and method development in an...
Varian CP-4900 Micro-GC from Varian, Inc.
Biology Products: